RxDoctor Payments Data

Mary Yang

Psychiatric/Mental Health · Waukesha, WINPI 1669995411

Payments from drug & device makers

$917in general payments, 2019–2025

Across 42 payments — averaging $21.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$125
  • Alkermes, Inc.$123
  • AbbVie$108
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$81
  • Indivior Inc.$79
  • Axsome Therapeutics, Inc.$73
  • plus $328 from 10 others

What the payments were for

  • Food & beverage$917100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$917 in reported general payments places this provider in the 65th percentile of 384 psychiatric/mental health providers in Wisconsin.

See all psychiatric/mental health providers in Wisconsin

Medicare billing

Part B allowed, 2024
$1,251
Medicare patients
12
Services billed
30

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate13$49,751
Paliperidone ErPaliperidone18$2,387
Aripiprazole37$2,043
Divalproex Sodium ErDivalproex Sodium21$1,992
Naltrexone Hcl37$1,654
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine12$1,507
Ramelteon12$1,252
Clozapine14$1,087
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl18$1,084
Hydroxyzine Hcl29$752
Buspirone Hcl23$654
Duloxetine Hcl16$626
Quetiapine Fumarate48$594
Olanzapine42$526
Venlafaxine Hcl ErVenlafaxine Hcl18$401

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$125$49,75113 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 384 psychiatric/mental health providers in Wisconsin.

Other psychiatric/mental health in Waukesha

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →